Item 5. Market for Registrant’s Common Equity
ITEM 5.
MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Our common stock has traded on the New York Stock Exchange (“NYSE”) since August 14, 2012, under the symbol “USPH”. Effective May 28, 2025, our common stock now also trades on the New
York Stock Exchange Texas (“NYSE TX”) under the symbol “USPH”.
As of February 27, 2026, there were 90 holders of record of our outstanding common stock.
DIVIDENDS
Our Board of Directors declared the following dividends during the year ended December 31, 2025:
Declaration Date
Record Date
Payment Date
Dividend Per Share
Aggregate Amount
(In thousands)
2/25/2025
3/14/2025
4/11/2025
$
0.45
$
6,836
5/6/2025
5/23/2025
6/13/2025
$
0.45
$
6,842
8/5/2025
8/22/2025
9/12/2025
$
0.45
$
6,842
11/4/2025
11/17/2025
12/12/2025
$
0.45
$
6,842
There is no assurance that future dividends will be declared. The declaration and payment of dividends in the future are at the discretion of our Board of Directors after taking into
account various factors, including, but not limited to, our financial condition, operating results, available cash and current and anticipated cash needs, and the terms of our Credit Agreement (as defined in “Item 7. Management’s Discussion
and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources”). We are currently restricted from paying dividends on our common stock in excess of $50.0 million in any fiscal year under the Credit Agreement.
FIVE YEAR PERFORMANCE GRAPH
The following performance graph compares the cumulative total stockholder return of our common stock to The NYSE Composite Index and the NYSE Health Care Index for the period from
December 31, 2020 through December 31, 2025. The graph assumes that $100 was invested in our common stock and the common stock of each of the companies listed on The NYSE Composite Index and the NYSE Health Care Index on December 31, 2020
and that any dividends were reinvested.
31
Table of Contents
Comparison of Five Years Cumulative Total Return for the Year Ended December 31, 2025
12/20
12/21
12/22
12/23
12/24
12/25
U. S. Physical Therapy, Inc.
100
79
67
77
74
65
NYSE Healthcare Index
100
121
117
121
121
134
The foregoing performance graph and related description shall not be deemed incorporated by reference into any filing under the Securities Act or under the Exchange Act, except to the
extent that we specifically incorporate this information by reference. In addition, the performance graph and the related description shall not be deemed “soliciting material” or “filed” with the SEC or subject to Regulation 14A or 14C.
PURCHASES OF EQUITY SECURITIES
The following table provides information about our repurchases of our common stock, that are registered pursuant to Section 12 of the Securities Exchange Act of 1934, during the three
months ended December 31, 2025. There were no additional repurchases in the year ended December 31, 2025, and no repurchases were made in the years ended December 31 2024, and December 31, 2023.
For the Month Ended
December 31, 2025
November 30, 2025
October 31, 2025
Number of shares repurchased
-
81,322
-
Total cost of shares repurchased
$
-
$
5,566,165
$
-
Average price (including brokers’ commission)
$
-
$
68.45
$
-
As of December 31, 2025, the Company had $19.4 million remaining available under its authorized share repurchase program.
32
Table of Contents
ITEM 6.
RESERVED